New Delhi: With Serum Institute of India (SII)-manufactured Oxford University’s Covishield has been rolled out in India as first COVID-19 vaccine, there are four more waiting for approval from the authorities.
According to Union Health Secretary Rajesh Bhushan, Zydus Cadila, Sputnik V, Biological E and Gennova are currently in advanced clinical trials stage in India. “In the coming days you may see some of these vaccines too approaching the drug controller for emergency use authorisation,” Bhushan was quoted as saying by NDTV.
The Health Ministry said that there will be a 28-day gap between two doses of COVID-19 vaccine and its effectiveness will begin 14 days after the second dose. The health secretary said vaccine effectiveness can be seen only after 14 days. “So we urge people to keep following Covid-appropriate behaviour,” Bhushan said.
ALSO READ: Vaccine To Work After 14 Days Of 2nd Shot, No Option To Choose Between Covishield…
Bhubaneswar: The opening date of Bhubaneswar and Cuttack Bali Jatras this year face a clash…
Bhubaneswar: A recent study has warned that humans and animals will be wiped out from…
Mumbai: Ever since ‘Pushpa 2: The Rule’ went on floors, speculation was rife that ‘Stree…
Kolkata: Sanjay Roy, the prime suspect in the brutal rape and murder of a Kolkata…
Bhubaneswar: Vigilance officials seized suspected ill-gotten money amounting to Rs 2.8 lakh from an official…
Baripada: A man was saved from drowning in a deep well due to timely rescue…
Mumbai: Actor Arjun Kapoor, who joined the third instalment of Rohit Shetty’s cop universe franchise…
New Delhi: Prime Minister Narendra Modi on Monday strongly condemned the “deliberate attack on a…